Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions
- PMID: 2113446
- DOI: 10.1016/0090-1229(90)90166-n
Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions
Abstract
We investigated 45 patients with Kawasaki disease (KD) and report the first simultaneous determination of tumor necrosis factor (TNF), interleukin 2 receptor (IL-2R) and interferon-gamma (IFN-gamma) in the serum during acute phase. Serum levels of TNF were measured by a sandwich enzyme-linked immunosorbent assay. Serum levels of soluble IL-2R and IFN-gamma were measured by a sandwich enzyme immunoassay and radioimmunoassay, respectively. Serum levels of TNF, IL-2R, and IFN-gamma were seen to increase during the acute phase of KD. In KD patients with coronary-artery lesions (CAL), the percentage of positive cases for TNF (greater than or equal to 10 U/ml), IL-2R (greater than or equal to 1056 U/ml), and IFN-gamma (greater than or equal to 0.3 U/ml) was higher than that in patients without CAL. Our results suggest that aggressive activation of immunocompetent cells develops in KD with CAL.
Similar articles
-
[Serum gamma interferon levels in relation to tumor necrosis factor and interleukin 2 receptor in patients with Kawasaki disease involving coronary-artery lesions].Arerugi. 1990 Feb;39(2 Pt 1):118-23. Arerugi. 1990. PMID: 2112909 Japanese.
-
[Role of ash2 (absent, small, or homeotic)-like and Jumonji domain-containing protein 3 on histone methylation of interferon-gamma gene and their associations with vascular damage of Kawasaki disease].Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Sep 24;45(9):791-798. doi: 10.3760/cma.j.issn.0253-3758.2017.09.012. Zhonghua Xin Xue Guan Bing Za Zhi. 2017. PMID: 29036979 Chinese.
-
Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.Heart Surg Forum. 2021 Jul 26;24(4):E611-E618. doi: 10.1532/hsf.3833. Heart Surg Forum. 2021. PMID: 34473042
-
Immunological abnormalities in Kawasaki disease with coronary artery lesions.Acta Paediatr Jpn. 1991 Dec;33(6):745-51. doi: 10.1111/j.1442-200x.1991.tb02603.x. Acta Paediatr Jpn. 1991. PMID: 1801554 Review.
-
The serum concentration of soluble interleukin-2 receptor in patients with Kawasaki disease.Ann Clin Biochem. 2017 Mar;54(2):209-213. doi: 10.1177/0004563216677583. Epub 2017 Jan 12. Ann Clin Biochem. 2017. PMID: 28081636 Review.
Cited by
-
Superantigen involvement and susceptibility factors in Kawasaki disease: profiles of TCR Vβ2+ T cells and HLA-DRB1, TNF-α and ITPKC genes among Filipino patients.Int J Mol Epidemiol Genet. 2013;4(1):70-6. Epub 2013 Mar 18. Int J Mol Epidemiol Genet. 2013. PMID: 23565324 Free PMC article.
-
Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer.Front Cardiovasc Med. 2023 Feb 10;10:1042272. doi: 10.3389/fcvm.2023.1042272. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36844744 Free PMC article.
-
Tumor necrosis factor-α-308 polymorphism is not associated with Kawasaki disease: A meta-analysis of case-control studies.Medicine (Baltimore). 2019 Jun;98(26):e15963. doi: 10.1097/MD.0000000000015963. Medicine (Baltimore). 2019. PMID: 31261503 Free PMC article.
-
Regulation of oxidative stress in patients with Kawasaki disease.Inflammation. 2012 Jun;35(3):952-8. doi: 10.1007/s10753-011-9398-1. Inflammation. 2012. PMID: 22012196 Clinical Trial.
-
Kawasaki disease: pathophysiology, clinical manifestations, and management.Curr Rheumatol Rep. 2014 Jun;16(6):423. doi: 10.1007/s11926-014-0423-x. Curr Rheumatol Rep. 2014. PMID: 24744086 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical